DIABETES CONTROL may be more challenging for Hispanics than for non-Hispanic whites, a meta-analysis suggests.

The FDA has approved Welchol (colesevelam hydrochloride) to reduce blood glucose in adults with type 2 diabetes mellitus in combination with metformin, sulfonylureas, or insulin, either alone or in combination with other agents, according to Daiichi Sankyo, Inc., of Parsippany, N.J.

SERUM URIC acid levels in the high-normal range are associated with reduced renal function in patients with type 1 diabetes, according to researchers.

Older individuals suffering from complications of type 2 diabetes are at increased risk of falling, researchers found.

Depomed, Inc., of Menlo Park, Calif., has received approval for 1,000-mg strength tablets of Glumetza (metformin hydrochloride extended-release tablets), which is indicated alone or in combination with a sulfonylurea or insulin as an adjunctive therapy to improve glycemic control in adult type 2 diabetes patients.

Depomed, Inc., of Menlo Park, Calif., has received approval for 1,000-mg strength tablets of Glumetza (metformin hydrochloride extended-release tablets), which is indicated alone or in combination with a sulfonylurea or insulin as an adjunctive therapy to improve glycemic control in adult type 2 diabetes patients.

DexCom, Inc., of San Diego, announced that it has received approval to calibrate Seven, its seven-day continuous glucose monitoring system, using any FDA-cleared blood glucose meter.

WITH 45% of dialysis patients presenting as a result of diabetic kidney disease or with comorbidity of diabetes, studies are examining blood sugar control as a means to improving outcomes for this large segment of the dialysis population.

Amylin Pharmaceuticals, Inc., of San Diego, announced the approval the SymlinPen 120 and the SymlinPen 60 pre-filled pen-injector devices for administering Symlin (pramlintide acetate) to improve mealtime glucose control.

CHICAGO—Diabetes increases the likelihood of UTI recurrences in pre- and post-menopausal women, despite longer treatments with more potent initial antibiotics, a Dutch study shows.